Welcome

This forum is for IRIS Industry users' discussion and self-help. You need to login to the portal with an IRIS account to post a new thread or reply to an existing one.
EMA staff monitors the forum and may intervene in conversation, however a reply cannot be guaranteed. This Forum does not replace the existing communication channels:
  • Questions on ongoing procedures at EMA should be submitted as a reply to any email received from IRIS regarding the specific case.
  • Use this form to send a request for information from the European Medicines Agency or to make a formal request for access to EMA documents that are not already published on the EMA website
  • Problems and technical issues about IRIS should be reported to the EMA ServiceNow. If you have difficulties in obtaining a role or affiliation to access IRIS, please select "IRIS account access and management" as the service, in the specific ServiceNow page.
Please do not post confidential information in the forum.
Thread Author Last post Replies
How to deal with an error in selecting a VMP (wrong MAH) Laure Gardey
Laure Gardey
0
Procedure Number vs Submission Number Gina Pereira
HRISHIKESH DHONGADE
2
RPI for an academic Nourredine Ait Rahmoune
Paolo Tomasi
1
Product specific waiver Zdenka Benesova
Paolo Tomasi
1
Fixe-dose combination, combination pack, co-administration: when are separate RPIs needed? Susan Weatherall
Paolo Tomasi
3
Transfer of Scientific Advice Costanza Vignoli
Paolo Tomasi
1
Procedure Tracking Number in EU M1 envelope - IRIS number Sonia Ouarti
Sonia Ouarti
0
PIP Annual Report, how to reflect when start date of the deferred study is not yet planned Nadine van Heesch
Nadine van Heesch
0
Acknowledgment of Day+25 PI submission Chiara Santangelo
Paolo Tomasi
1
update substance name Annabella Amatulli
Paolo Tomasi
1
PIP Annual Report Andreas Eriksson
Paolo Tomasi
1
Acknowledgment of receipt of Type IA Variation from EMA IRIS. Esmail Samiwala
Esmail Samiwala
0
Question related to the VNees format in IRIS David Holguin
Anna Vecellio
1
Lead MAH in PSUSA procedure Linda Garner
Linda Garner
0
QPPV access clarification Linda Garner
Linda Garner
0
PIP modification to remove Studies Angela Pizzatti
Giovanni Lesa
3
IRIS Roles from Multiple Organizations Brian Caselli
Paolo Tomasi
1
PIP waiver application Helen Crowley
Paolo Tomasi
1
General questions about IRIS David Holguin
Paolo Tomasi
1
IRIS Marketing Status Reporting for UK Northern Ireland - Windsor Framework Roberta Bernardelli
Roberta Bernardelli
1

You must be signed in to post in this forum.